Beta Bionics, Inc. (BBNX)
16.73
-0.85
(-4.84%)
USD |
NASDAQ |
Oct 30, 16:00
16.73
0.00 (0.00%)
After-Hours: 20:00
Beta Bionics Cash from Investing (Quarterly) : -114.08M for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -114.08M |
| June 30, 2026 | 26.93M |
| March 31, 2026 | 21.84M |
| December 31, 2025 | 0.658M |
| September 30, 2025 | 9.486M |
| June 30, 2025 | 6.173M |
| Date | Value |
|---|---|
| March 31, 2025 | -179.12M |
| December 31, 2024 | -29.66M |
| September 30, 2024 | 15.24M |
| June 30, 2024 | 3.30M |
| March 31, 2024 | 7.644M |
| December 31, 2023 | -69.61M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| PROCEPT BioRobotics Corp. | -2.953M |
| Edwards Lifesciences Corp. | -193.20M |
| Intuitive Surgical, Inc. | 1.898B |
| Stryker Corp. | -639.00M |
| Zimmer Biomet Holdings, Inc. | -190.80M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.29M |
| Cash from Financing (Quarterly) | 163.60M |
| Free Cash Flow | -65.96M |
| Free Cash Flow Per Share (Quarterly) | -0.3129 |
| Free Cash Flow to Equity (Quarterly) | -14.15M |
| Free Cash Flow to Firm (Quarterly) | -14.56M |
| Free Cash Flow Yield | -8.78% |